Full Press Release Details
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports Third Quarter Financial Results for 2026
BMY Neutral Sentiment
Bristol Myers Squibb Reports Third Quarter Financial Results for 2026
Key Takeaway: Bristol Myers Squibb announced its financial results for the third quarter of 2026. The report was released from Princeton, N.J., but specific financial figures or insights were not detailed in the announcement. The results are part of the company's ongoing financial disclosures.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+14%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Iza-bren
Phase 3 · Non-Small Cell Lung Cancer
Frequently Asked Questions
What financial period does this report cover?
The report covers Bristol Myers Squibb's financial results for the third quarter of 2026.
Where is Bristol Myers Squibb headquartered?
The company is headquartered in Princeton, New Jersey, as stated in the press release.
Who issued the financial results announcement?
Bristol Myers Squibb issued the announcement via Business Wire on behalf of the corporation.
What is the ticker symbol for this company?
The ticker symbol for Bristol Myers Squibb is BMY, as identified in the article metadata.